Epitope Design from Transporter Targets in N. gonorrhoeae |
| Debmalya Barh1* and Amarendra Narayana Misra2 |
1Centre for Genomics and Applied Gene Technology, IIOAB, Nonakuri, Purba Medinipur, West Bengal, India |
| 2Dept of Biosciences and Biotechnology, Fakir Mohan University, Balasore, Orissa, India |
| *Corresponding author: |
Dr. Debmalya Barh,
Centre for Genomics and
Applied Gene Technology,
IIOAB, Nonakuri, Purba Medinipur, WB-
721172, India,
Tel : +91-9449 5500 32,
E-mail: dr.barh@gmail.com |
|
| Received October 04, 2009; Accepted November 24, 2009; Published
November 24, 2009 |
Citation: Barh D, Misra AN (2009) Epitope Design from Transporter Targets
in N. gonorrhoeae. J Proteomics Bioinform 2: 475-480.. doi: 10.4172/jpb.1000108 |
Copyright: ©2009 Barh D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author
and source are credited. |
| Abstract |
Gonococcal infection and transmission is a global health
problem and till date no effective vaccine is available to
prevent the disease transmission. Recently, analysing membrane
proteome of N. gonorrhoeae we have shown that,
several membrane associated proteins of the gonococcus
might be important in developing anti-gonorrhoea drugs.
Here, we explored the possibility of such 19 essential
membrane transporter targets those may be useful in developing
peptide vaccines too. Using a classical in silico technique, we have identified four best epitopes from three
transporters. All identified epitopes are antigenic and predicted
to induce both the T- and B-cell mediated immune
responses and transmembrane helix prediction shows that,
selected epitopes are mostly outside of the membrane that
indicates the suitability of these epitopes to be potential
peptide vaccine candidates. Identified epitopes require experimental
validation. |
|
|
|